Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer

The Journal of Clinical Endocrinology and Metabolism
P PujolC Jaffiol

Abstract

We investigate whether the prognosis of patients with differentiated thyroid cancer is improved by maintaining a greater level of TSH suppression. One hundred and forty-one patients who underwent hormone therapy after thyroidectomy were followed up from 1970 to 1993 (mean, 95 months). Patients received levothyroxine (L-T4; mean dose, 2.6 micrograms/kg-day). TSH suppression was evaluated by TRH stimulation test until 1986 and thereafter by a second generation immunoradiometric assay. As TSH underwent fluctuation over time in most patients, we focused on subgroups of patients with relatively constant TSH levels during the follow-up. The relapse-free survival (RFS) was longer in the group with constantly suppressed TSH (all TSH values, < or = 0.05 mU/L; n = 18) than in the group with nonsuppressed TSH (all TSH values, > or = 1 mU/L; n = 15; P < 0.01). Age, sex, tumor node metastasis stage, and initial therapy were not different between the suppressed and nonsuppressed TSH groups. In the overall population, we analyzed the level of TSH suppression by studying the percentage of undetectable TSH values (< or = 0.05 mU/L) during the follow-up. The patients with a greater degree of TSH suppression (> 90% of undetectable TSH values; n =...Continue Reading

Citations

Sep 16, 2008·Thyroid : Official Journal of the American Thyroid Association·Jacqueline JonklaasSteven J Soldin
Jun 23, 2009·Journal of Endocrinological Investigation·P Zanotti-FregonaraE Hindié
Jan 6, 2010·World Journal of Surgery·Stergios A Polyzos, Athanasios D Anastasilakis
Dec 22, 2004·Current Treatment Options in Oncology·Jyotika K FernandesAnand K Sharma
Jun 12, 2002·Current Treatment Options in Oncology·E Yutan, O H Clark
Jun 22, 2005·Current Treatment Options in Oncology·Richard T Kloos
Jun 14, 2002·Current Treatment Options in Oncology·O Alsanea
Mar 11, 2008·Journal of Cancer Research and Clinical Oncology·Stergios A PolyzosAvraam Avramidis
Jul 15, 2004·Oncology Nursing Forum·Muriel J Montbriand
Mar 24, 2016·Endocrine Journal·Pierpaolo TrimboliCamilla Virili
Feb 16, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Dong Wook ShinYoungmin Park
Mar 8, 2018·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Karla DucciniMario Vaisman
Oct 30, 2019·World Journal of Surgery·Maximilian ZoltekCaroline Nordenvall
Aug 25, 2019·Journal of Clinical Medicine·Yu-Mi LeeSuck Joon Hong
Oct 2, 2003·British Journal of Cancer·M V Blagosklonny
Aug 31, 2017·Journal of Endocrinological Investigation·G R Williams, J H D Bassett
Jun 3, 2017·International Journal of Endocrinology·Carlo CappelliMaurizio Castellano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.